Fidelity Investments’s Immix Biopharma IMMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.42K Buy
809
+748
+1,226% +$8.47K ﹤0.01% 4987
2026
Q2
$629 Buy
+61
New +$566 ﹤0.01% 5292
2023
Q1
– Sell
-7
Closed -$16 – 5405
2022
Q4
$16 Sell
7
-2
-22% -$3 ﹤0.01% 5167
2022
Q3
$12 Buy
+9
New +$20 ﹤0.01% 5201

Other funds holding IMMX

Fidelity Investments's IMMX Position: Q3 2026 in Review

Fidelity Investments increased its Immix Biopharma (IMMX) stake by 1,226% in Q3 2026, buying an estimated $8.47K and bringing the position to 809 shares worth $8.42K. The position accounts for ﹤0.01% of the portfolio, ranked #4987.

Fidelity Investments first reported a position in IMMX in Q3 2022 and has held it in 4 quarters since. 137 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.

  • Fidelity Investments held 809 shares of Immix Biopharma worth $8.42K as of Q3 2026.
  • Fidelity Investments bought 748 Immix Biopharma shares in Q3 2026, an estimated $8.47K.
  • Immix Biopharma made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #4987 holding.
  • Fidelity Investments first reported a position in Immix Biopharma in Q3 2022 and has held it in 4 quarters since.
  • 137 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.